Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Hyperplasia | 6 | 2021 | 523 | 1.220 |
Why?
|
Embolization, Therapeutic | 12 | 2021 | 1392 | 1.160 |
Why?
|
Radiology, Interventional | 9 | 2022 | 460 | 1.100 |
Why?
|
Adrenal Cortex Neoplasms | 2 | 2017 | 162 | 1.010 |
Why?
|
Adrenalectomy | 2 | 2017 | 341 | 0.990 |
Why?
|
Catheter Ablation | 11 | 2021 | 2758 | 0.990 |
Why?
|
Hyperaldosteronism | 2 | 2017 | 240 | 0.910 |
Why?
|
Radiography, Interventional | 8 | 2020 | 1095 | 0.840 |
Why?
|
Prostate | 7 | 2021 | 1775 | 0.840 |
Why?
|
Aldosterone | 2 | 2017 | 877 | 0.810 |
Why?
|
Uterine Artery Embolization | 3 | 2020 | 62 | 0.800 |
Why?
|
Hepatic Artery | 2 | 2018 | 245 | 0.620 |
Why?
|
After-Hours Care | 1 | 2018 | 102 | 0.600 |
Why?
|
Adrenocortical Adenoma | 1 | 2017 | 48 | 0.580 |
Why?
|
Blood Pressure Determination | 1 | 2018 | 633 | 0.480 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2015 | 95 | 0.470 |
Why?
|
Tetracycline | 3 | 2002 | 214 | 0.430 |
Why?
|
Magnetic Resonance Angiography | 3 | 2016 | 1443 | 0.420 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2015 | 273 | 0.420 |
Why?
|
Surgery, Computer-Assisted | 3 | 2013 | 1018 | 0.370 |
Why?
|
Leiomyoma | 5 | 2020 | 730 | 0.370 |
Why?
|
Arteries | 6 | 2021 | 1119 | 0.350 |
Why?
|
Bacterial Translocation | 4 | 2002 | 73 | 0.340 |
Why?
|
Liver Diseases | 2 | 2015 | 1253 | 0.330 |
Why?
|
Radial Artery | 2 | 2020 | 194 | 0.320 |
Why?
|
Antibiotic Prophylaxis | 3 | 2002 | 639 | 0.310 |
Why?
|
Ischemia | 1 | 2016 | 1907 | 0.300 |
Why?
|
Catheterization, Peripheral | 2 | 2020 | 345 | 0.280 |
Why?
|
Catheterization, Central Venous | 2 | 2008 | 514 | 0.280 |
Why?
|
Renal Dialysis | 2 | 2022 | 1783 | 0.280 |
Why?
|
Adenoma | 2 | 2016 | 2174 | 0.270 |
Why?
|
Escherichia coli Infections | 4 | 2002 | 532 | 0.240 |
Why?
|
Bile Duct Neoplasms | 2 | 2021 | 567 | 0.240 |
Why?
|
Hypertension | 3 | 2018 | 8479 | 0.230 |
Why?
|
Omeprazole | 1 | 2004 | 112 | 0.230 |
Why?
|
Liver Neoplasms | 4 | 2021 | 4253 | 0.220 |
Why?
|
Liver Transplantation | 2 | 2018 | 2119 | 0.220 |
Why?
|
Hemorrhage | 1 | 2015 | 3461 | 0.220 |
Why?
|
Esophagitis | 1 | 2004 | 152 | 0.220 |
Why?
|
Acute Kidney Injury | 1 | 2015 | 1968 | 0.210 |
Why?
|
Contrast Media | 2 | 2015 | 5300 | 0.210 |
Why?
|
Fibroadenoma | 1 | 2021 | 43 | 0.200 |
Why?
|
Bronchodilator Agents | 1 | 2004 | 502 | 0.190 |
Why?
|
Uterine Neoplasms | 4 | 2019 | 1513 | 0.190 |
Why?
|
Short Bowel Syndrome | 2 | 2020 | 345 | 0.190 |
Why?
|
Drug Costs | 1 | 2018 | 1105 | 0.190 |
Why?
|
Transurethral Resection of Prostate | 1 | 2021 | 83 | 0.190 |
Why?
|
Retrospective Studies | 23 | 2021 | 77460 | 0.180 |
Why?
|
Liver | 2 | 2018 | 7475 | 0.180 |
Why?
|
Graft Survival | 3 | 2018 | 3737 | 0.180 |
Why?
|
Glucagon-Like Peptide 2 | 1 | 2020 | 50 | 0.180 |
Why?
|
Antidiarrheals | 1 | 2020 | 45 | 0.180 |
Why?
|
Electromagnetic Phenomena | 1 | 2020 | 161 | 0.180 |
Why?
|
Parenteral Nutrition, Home | 1 | 2020 | 35 | 0.180 |
Why?
|
Thrombectomy | 1 | 2004 | 680 | 0.170 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 2019 | 60 | 0.170 |
Why?
|
Eosinophilia | 1 | 2004 | 541 | 0.170 |
Why?
|
Graft Occlusion, Vascular | 2 | 2022 | 549 | 0.170 |
Why?
|
Lung | 3 | 2021 | 9857 | 0.170 |
Why?
|
Venous Thrombosis | 1 | 2008 | 1239 | 0.170 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2022 | 277 | 0.170 |
Why?
|
Sepsis | 3 | 2002 | 2593 | 0.170 |
Why?
|
Peer Review, Health Care | 1 | 2019 | 75 | 0.160 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2020 | 182 | 0.160 |
Why?
|
Uterine Hemorrhage | 1 | 2019 | 255 | 0.150 |
Why?
|
Motor Skills | 1 | 2020 | 522 | 0.150 |
Why?
|
Treatment Outcome | 19 | 2021 | 63107 | 0.150 |
Why?
|
Intention to Treat Analysis | 1 | 2018 | 426 | 0.150 |
Why?
|
Hypnosis | 2 | 2008 | 82 | 0.140 |
Why?
|
Gastroesophageal Reflux | 1 | 2004 | 782 | 0.140 |
Why?
|
Cryosurgery | 1 | 2021 | 453 | 0.140 |
Why?
|
Catheters, Indwelling | 2 | 2010 | 426 | 0.140 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 516 | 0.140 |
Why?
|
Kidney Failure, Chronic | 1 | 2008 | 2535 | 0.130 |
Why?
|
Postpartum Hemorrhage | 1 | 2019 | 258 | 0.130 |
Why?
|
Nitric Oxide | 1 | 2004 | 2132 | 0.130 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4153 | 0.130 |
Why?
|
Hand | 1 | 2020 | 884 | 0.130 |
Why?
|
Humans | 52 | 2022 | 744366 | 0.130 |
Why?
|
Femoral Artery | 1 | 2019 | 845 | 0.130 |
Why?
|
Graft Rejection | 1 | 2018 | 4397 | 0.130 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2011 | 740 | 0.130 |
Why?
|
Triiodobenzoic Acids | 1 | 2015 | 124 | 0.130 |
Why?
|
Teaching Rounds | 1 | 2019 | 253 | 0.130 |
Why?
|
Brazil | 2 | 2016 | 1270 | 0.120 |
Why?
|
Middle Aged | 25 | 2020 | 213390 | 0.120 |
Why?
|
End Stage Liver Disease | 1 | 2018 | 314 | 0.120 |
Why?
|
Boston | 3 | 2016 | 9312 | 0.120 |
Why?
|
Cholestasis | 1 | 2017 | 378 | 0.120 |
Why?
|
Angioplasty, Balloon | 1 | 2018 | 653 | 0.120 |
Why?
|
Telemedicine | 2 | 2022 | 2872 | 0.120 |
Why?
|
Female | 31 | 2021 | 380193 | 0.120 |
Why?
|
Length of Stay | 2 | 2018 | 6311 | 0.120 |
Why?
|
Gelatin | 2 | 2012 | 225 | 0.110 |
Why?
|
Radiology Information Systems | 1 | 2017 | 523 | 0.110 |
Why?
|
Fluoroscopy | 1 | 2017 | 924 | 0.110 |
Why?
|
Terminology as Topic | 1 | 2020 | 1547 | 0.110 |
Why?
|
Patient Care Planning | 2 | 2017 | 921 | 0.100 |
Why?
|
Male | 26 | 2021 | 350115 | 0.100 |
Why?
|
Intestines | 2 | 2020 | 1924 | 0.100 |
Why?
|
Pulmonary Embolism | 1 | 2004 | 2375 | 0.100 |
Why?
|
Rats, Wistar | 5 | 2002 | 1892 | 0.100 |
Why?
|
Angiography | 2 | 2009 | 1639 | 0.100 |
Why?
|
Biopsy | 3 | 2020 | 6755 | 0.100 |
Why?
|
Breast Neoplasms | 2 | 2021 | 20824 | 0.100 |
Why?
|
Ablation Techniques | 1 | 2013 | 249 | 0.090 |
Why?
|
Yttrium Radioisotopes | 2 | 2021 | 93 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 4 | 2021 | 35425 | 0.090 |
Why?
|
Time Factors | 7 | 2020 | 40075 | 0.090 |
Why?
|
Creatinine | 1 | 2015 | 1919 | 0.090 |
Why?
|
Learning | 1 | 2019 | 1711 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2214 | 0.080 |
Why?
|
Punctures | 2 | 2020 | 374 | 0.080 |
Why?
|
Sonication | 1 | 2009 | 83 | 0.080 |
Why?
|
Bombesin | 1 | 2008 | 34 | 0.080 |
Why?
|
Colectomy | 1 | 2013 | 680 | 0.080 |
Why?
|
Organotechnetium Compounds | 1 | 2008 | 137 | 0.080 |
Why?
|
Microspheres | 2 | 2021 | 777 | 0.080 |
Why?
|
Clinical Competence | 2 | 2020 | 4687 | 0.080 |
Why?
|
Equipment Design | 2 | 2013 | 3582 | 0.080 |
Why?
|
Vascular Patency | 2 | 2022 | 887 | 0.080 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2008 | 191 | 0.080 |
Why?
|
Pancreas Transplantation | 1 | 2008 | 187 | 0.080 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2008 | 129 | 0.080 |
Why?
|
Catheterization | 2 | 2010 | 1470 | 0.070 |
Why?
|
Bacteria | 1 | 2018 | 2115 | 0.070 |
Why?
|
Adult | 20 | 2020 | 214052 | 0.070 |
Why?
|
Venous Insufficiency | 1 | 2008 | 103 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2010 | 550 | 0.070 |
Why?
|
Hepatectomy | 1 | 2010 | 550 | 0.070 |
Why?
|
Antihypertensive Agents | 1 | 2016 | 2047 | 0.070 |
Why?
|
Femoral Vein | 1 | 2007 | 159 | 0.070 |
Why?
|
Italy | 1 | 2018 | 832 | 0.070 |
Why?
|
Empathy | 2 | 2008 | 474 | 0.070 |
Why?
|
Foot | 1 | 2010 | 527 | 0.070 |
Why?
|
Blood Coagulation | 2 | 2009 | 1127 | 0.070 |
Why?
|
Diabetic Foot | 1 | 2010 | 355 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 7 | 2016 | 20130 | 0.070 |
Why?
|
Aged | 12 | 2020 | 163288 | 0.070 |
Why?
|
Risk Factors | 6 | 2019 | 72296 | 0.070 |
Why?
|
Laser Coagulation | 1 | 2008 | 326 | 0.070 |
Why?
|
Relaxation Therapy | 1 | 2006 | 178 | 0.060 |
Why?
|
Peripheral Arterial Disease | 1 | 2016 | 1188 | 0.060 |
Why?
|
Consensus | 3 | 2020 | 2960 | 0.060 |
Why?
|
Vena Cava Filters | 1 | 2008 | 253 | 0.060 |
Why?
|
Arteriovenous Fistula | 1 | 2008 | 315 | 0.060 |
Why?
|
Saphenous Vein | 1 | 2008 | 532 | 0.060 |
Why?
|
Patient Selection | 2 | 2013 | 4216 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2018 | 5316 | 0.060 |
Why?
|
Cimetidine | 1 | 2004 | 78 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7914 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 5984 | 0.060 |
Why?
|
2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2004 | 35 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3743 | 0.060 |
Why?
|
Niacinamide | 2 | 2021 | 416 | 0.060 |
Why?
|
Leukocyte Count | 1 | 2008 | 1588 | 0.060 |
Why?
|
Uterus | 1 | 2008 | 711 | 0.060 |
Why?
|
Suction | 1 | 2004 | 267 | 0.060 |
Why?
|
Transplantation Tolerance | 1 | 2018 | 617 | 0.060 |
Why?
|
Ureteral Calculi | 1 | 2004 | 110 | 0.060 |
Why?
|
Cost Savings | 1 | 2018 | 925 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14723 | 0.050 |
Why?
|
Histamine H2 Antagonists | 1 | 2004 | 165 | 0.050 |
Why?
|
Escherichia coli | 3 | 2000 | 4217 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5223 | 0.050 |
Why?
|
Blood Pressure | 1 | 2018 | 8551 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3135 | 0.050 |
Why?
|
Ureteral Obstruction | 1 | 2004 | 296 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3242 | 0.050 |
Why?
|
Esophagoscopy | 1 | 2004 | 390 | 0.050 |
Why?
|
Colony-Forming Units Assay | 1 | 2002 | 356 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3508 | 0.050 |
Why?
|
Administration, Inhalation | 1 | 2004 | 1105 | 0.050 |
Why?
|
Stents | 3 | 2022 | 3282 | 0.050 |
Why?
|
Vena Cava, Inferior | 2 | 2002 | 440 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2016 | 19905 | 0.050 |
Why?
|
Biopsy, Needle | 1 | 2006 | 1641 | 0.050 |
Why?
|
Tetracyclines | 1 | 2000 | 60 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 1620 | 0.050 |
Why?
|
Vascular Surgical Procedures | 1 | 2009 | 1476 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4933 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2021 | 295 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.040 |
Why?
|
Pregnancy | 2 | 2019 | 29144 | 0.040 |
Why?
|
Dilatation and Curettage | 1 | 2019 | 56 | 0.040 |
Why?
|
Thrombolytic Therapy | 1 | 2009 | 2162 | 0.040 |
Why?
|
Postoperative Complications | 3 | 2011 | 15297 | 0.040 |
Why?
|
Blood Glucose | 1 | 2013 | 6254 | 0.040 |
Why?
|
Prednisone | 1 | 2004 | 1574 | 0.040 |
Why?
|
Rats | 5 | 2002 | 24252 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2018 | 5388 | 0.040 |
Why?
|
Prognosis | 2 | 2016 | 29060 | 0.040 |
Why?
|
Palliative Care | 1 | 2013 | 3493 | 0.040 |
Why?
|
Aged, 80 and over | 5 | 2017 | 57776 | 0.040 |
Why?
|
Forms and Records Control | 1 | 2019 | 160 | 0.040 |
Why?
|
Off-Label Use | 1 | 2020 | 169 | 0.040 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 528 | 0.040 |
Why?
|
Esophagus | 1 | 2004 | 1019 | 0.040 |
Why?
|
Breast | 1 | 2006 | 1970 | 0.040 |
Why?
|
Angiography, Digital Subtraction | 1 | 2018 | 341 | 0.040 |
Why?
|
Bacterial Adhesion | 1 | 1998 | 316 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13104 | 0.040 |
Why?
|
Infant | 1 | 2018 | 35134 | 0.030 |
Why?
|
Canada | 1 | 2021 | 2065 | 0.030 |
Why?
|
Physical Examination | 2 | 2013 | 1237 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2020 | 5077 | 0.030 |
Why?
|
Pain | 2 | 2008 | 4988 | 0.030 |
Why?
|
Risk Assessment | 2 | 2013 | 23336 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5749 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2018 | 1107 | 0.030 |
Why?
|
Outpatients | 1 | 2022 | 1487 | 0.030 |
Why?
|
Fertility | 1 | 2019 | 781 | 0.030 |
Why?
|
Workflow | 1 | 2019 | 847 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2013 | 6773 | 0.030 |
Why?
|
Abortion, Induced | 1 | 2019 | 458 | 0.030 |
Why?
|
Databases, Factual | 1 | 2018 | 7730 | 0.030 |
Why?
|
Algorithms | 1 | 2013 | 13882 | 0.030 |
Why?
|
Body Height | 1 | 2019 | 1578 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2021 | 1928 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3799 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2016 | 1525 | 0.030 |
Why?
|
Animals | 9 | 2020 | 168768 | 0.030 |
Why?
|
Neoplasms | 2 | 2013 | 21696 | 0.030 |
Why?
|
Ambulatory Care | 1 | 2022 | 2708 | 0.020 |
Why?
|
Brain | 1 | 2018 | 26388 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39052 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2008 | 4262 | 0.020 |
Why?
|
Hemothorax | 1 | 2011 | 60 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2727 | 0.020 |
Why?
|
Prospective Studies | 3 | 2021 | 53290 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2022 | 3395 | 0.020 |
Why?
|
Hemostatics | 1 | 2012 | 229 | 0.020 |
Why?
|
Medical History Taking | 1 | 2013 | 784 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3528 | 0.020 |
Why?
|
Ankle Brachial Index | 1 | 2010 | 154 | 0.020 |
Why?
|
Nitrogen Compounds | 1 | 2008 | 6 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2012 | 1423 | 0.020 |
Why?
|
Reoperation | 1 | 2018 | 4201 | 0.020 |
Why?
|
Phosphines | 1 | 2008 | 18 | 0.020 |
Why?
|
Receptors, Bombesin | 1 | 2008 | 27 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2004 | 12961 | 0.020 |
Why?
|
Acrylic Resins | 1 | 2008 | 142 | 0.020 |
Why?
|
Pain Measurement | 2 | 2008 | 3420 | 0.020 |
Why?
|
Drug Stability | 1 | 2008 | 291 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2008 | 380 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2008 | 18034 | 0.020 |
Why?
|
Dogs | 1 | 2012 | 3912 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8319 | 0.020 |
Why?
|
Limb Salvage | 1 | 2010 | 433 | 0.020 |
Why?
|
Angioplasty | 1 | 2010 | 364 | 0.020 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2008 | 407 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2011 | 662 | 0.020 |
Why?
|
Isotope Labeling | 1 | 2008 | 406 | 0.020 |
Why?
|
Hydrazines | 1 | 2008 | 226 | 0.020 |
Why?
|
Patients' Rooms | 1 | 2006 | 63 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2009 | 868 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1998 | 4459 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2011 | 885 | 0.020 |
Why?
|
Hematoma | 1 | 2011 | 758 | 0.020 |
Why?
|
Hemodynamics | 1 | 2016 | 4196 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15078 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2008 | 11126 | 0.020 |
Why?
|
Tumor Burden | 1 | 2011 | 1915 | 0.020 |
Why?
|
Lidocaine | 1 | 2008 | 544 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2008 | 692 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2086 | 0.020 |
Why?
|
Preoperative Care | 1 | 2013 | 2251 | 0.020 |
Why?
|
Equipment Failure | 1 | 2007 | 578 | 0.020 |
Why?
|
Parenteral Nutrition, Total | 1 | 2005 | 302 | 0.020 |
Why?
|
Necrosis | 1 | 2008 | 1643 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2008 | 397 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2008 | 2031 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2008 | 2327 | 0.010 |
Why?
|
Models, Economic | 1 | 2008 | 712 | 0.010 |
Why?
|
Cysteine | 1 | 2008 | 873 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9240 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6896 | 0.010 |
Why?
|
Anxiety | 2 | 2008 | 4293 | 0.010 |
Why?
|
Drug Design | 1 | 2008 | 1076 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 1375 | 0.010 |
Why?
|
Weight Loss | 1 | 2013 | 2625 | 0.010 |
Why?
|
Rabbits | 1 | 2008 | 4894 | 0.010 |
Why?
|
Doxorubicin | 1 | 2008 | 2234 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2887 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3252 | 0.010 |
Why?
|
Pancreas | 1 | 2008 | 1687 | 0.010 |
Why?
|
Anesthetics, Local | 1 | 2008 | 985 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2013 | 3531 | 0.010 |
Why?
|
Ultrasonography, Interventional | 1 | 2008 | 1486 | 0.010 |
Why?
|
Digestive System Surgical Procedures | 1 | 2005 | 576 | 0.010 |
Why?
|
Child | 2 | 2005 | 77709 | 0.010 |
Why?
|
Survival Rate | 1 | 2013 | 12788 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 56429 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2011 | 3280 | 0.010 |
Why?
|
Renal Veins | 1 | 1998 | 108 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15535 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2645 | 0.010 |
Why?
|
Particulate Matter | 1 | 2009 | 2529 | 0.010 |
Why?
|
United States | 2 | 2020 | 69872 | 0.010 |
Why?
|
Death | 1 | 2002 | 678 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2008 | 2575 | 0.010 |
Why?
|
Ultrasonography | 1 | 2010 | 5984 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8642 | 0.010 |
Why?
|
Laparotomy | 1 | 1998 | 473 | 0.010 |
Why?
|
Portal Vein | 1 | 1998 | 437 | 0.010 |
Why?
|
Body Mass Index | 1 | 2013 | 12721 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 21748 | 0.010 |
Why?
|
Health Care Costs | 1 | 2006 | 3208 | 0.010 |
Why?
|
Pulmonary Veins | 1 | 1998 | 761 | 0.010 |
Why?
|
Survival Analysis | 1 | 2005 | 10252 | 0.010 |
Why?
|
Melanoma | 1 | 2011 | 5511 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 16690 | 0.010 |
Why?
|
Mice | 1 | 2008 | 81201 | 0.000 |
Why?
|
Adolescent | 1 | 2005 | 85779 | 0.000 |
Why?
|